MedTrace Logo

Role of Active Deresuscitation After Resuscitation-2

NCT03512392 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2022-04-21

No results posted yet for this study

Summary

RADAR-2 will be a randomised, open-label, allocation concealed, pilot trial of conservative fluid administration and deresuscitation compared with usual care in patients who are critically ill.

Conditions

Interventions

OTHER

Conservative fluid and deresuscitation strategy

Conservative administration of intravenous fluid and active deresuscitation using diuretics or renal replacement therapy for eligible patients

OTHER

Usual care strategy

Usual care at the discretion of the clinical team

Sponsors & Collaborators

  • Queen's University, Belfast

    collaborator OTHER

  • University of Toronto

    collaborator OTHER

  • Belfast Health and Social Care Trust

    lead OTHER

Principal Investigators

  • Jon Silversides, MB BCh · Belfast Health and Social Care Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-10
Primary Completion
2020-01-21
Completion
2021-07-17

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03512392 on ClinicalTrials.gov